Medical Imaging Corp

Medical Imaging Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.41, below the median for its industry, and a current ratio of 3.04, indicating strong short-term liquidity. However, the company's operating cash flow is negative at -294.39 million TWD, while free cash flow is positive at 113.57 million TWD, suggesting that capital expenditures are being funded internally. The company's liquidity position is rated as medium, with a key flag indicating that net cash is negative after subtracting total debt. In terms of profitability, Medical Imaging Corp reports a return on equity (ROE) of 16.56% and a return on assets (ROA) of 9.69%, both exceeding the industry median for ROE and ROA. The company's operating margin is 19.15% (223.04 million TWD operating income on 1.16 billion TWD revenue), which is strong relative to its peers. The company's revenue is concentrated in a single business segment focused on medical equipment and services, with no disclosed geographic diversification. This concentration increases exposure to regional demand fluctuations and regulatory changes in the healthcare sector. Outlook for the current fiscal year shows a projected revenue growth of 4.5% year-over-year, with a 2.1% increase in operating income. For the next fiscal year, revenue is expected to grow by 3.8%, with a 1.9% increase in operating income. These projections are supported by a stable capital expenditure outlook and a modest increase in operating margins. The company's risk assessment indicates a low dilution potential, with no near-term pressure from share issuance or convertible debt. However, the negative operating cash flow and reliance on internal funding for capital expenditures may limit flexibility in the event of a downturn. The risk assessment also highlights a medium liquidity risk due to the negative net cash position after debt. Recent filings and transcripts indicate that the company is expanding its leasing services and consulting offerings to diversify revenue streams. No major regulatory or legal risks were disclosed in the latest filings, though the healthcare sector remains subject to evolving regulations in Taiwan.